Found: 113
Select item for more details and to access through your institution.
Key Roles of CACNA1C/Cav1.2 and CALB1/Calbindin in Prefrontal Neurons Altered in Cognitive Disorders.
- Published in:
- JAMA Psychiatry, 2024, v. 81, n. 9, p. 870, doi. 10.1001/jamapsychiatry.2024.1112
- By:
- Publication type:
- Article
BDNF Variants, Premorbid Educational Attainment, and Disease Characteristics in Alzheimer's Disease: An Exploratory Study.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 17, n. 4, p. 887, doi. 10.3233/JAD-2009-1106
- By:
- Publication type:
- Article
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
- Published in:
- 2008
- By:
- Publication type:
- journal article
High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 15, p. 1774, doi. 10.1001/jama.300.15.1774
- By:
- Publication type:
- Article
Clarifying Confusion: The Confusion Assessment Method.
- Published in:
- Annals of Internal Medicine, 1990, v. 113, n. 12, p. 941, doi. 10.7326/0003-4819-113-12-941
- By:
- Publication type:
- Article
Natural cubic splines for the analysis of Alzheimer's clinical trials.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 3, p. 508, doi. 10.1002/pst.2285
- By:
- Publication type:
- Article
[<sup>123</sup>I]5-IA-85380 SPECT Imaging of β<sub>2</sub>-Nicotinic Acetylcholine Receptor Availability in the Aging Human Brain.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1097, p. 168, doi. 10.1196/annals.1379.015
- By:
- Publication type:
- Article
Apolipoprotein E ɛ4 Allele Increases Risk for Psychotic Symptoms in Alzheimer's Disease.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 1, p. 171, doi. 10.1038/sj.npp.1301148
- By:
- Publication type:
- Article
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00213
- By:
- Publication type:
- Article
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0119-0
- By:
- Publication type:
- Article
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.
- Published in:
- Annals of Neurology, 2015, v. 77, n. 6, p. 953, doi. 10.1002/ana.24394
- By:
- Publication type:
- Article
<sup>123</sup>I-5-IA-85380 SPECT Imaging of Nicotinic Receptors in Alzheimer Disease and Mild Cognitive Impairment.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 9, p. 1455, doi. 10.2967/jnumed.109.064030
- By:
- Publication type:
- Article
<sup>123</sup>I-5-IA-85380 SPECT Imaging of Nicotinic Acetylcholine Receptor Availability in Nonsmokers: Effects of Sex and Menstrual Phase.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 10, p. 1633, doi. 10.2967/jnumed.107.042317
- By:
- Publication type:
- Article
<sup>123</sup>I-5-IA-85380 SPECT Measurement of Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 9, p. 1466
- By:
- Publication type:
- Article
Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 5, p. 745
- By:
- Publication type:
- Article
PET Quantification of 5-HT<sub>2A</sub> Receptors in the Human Brain: A Constant Infusion Paradigm with [<sup>18</sup>F]Altanserin.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 2, p. 234
- By:
- Publication type:
- Article
Iodine- 123-β-CIT and Iodine-123-FPCIT SPECT Measurement of Dopamine Transporters in Healthy Subjects and Parkinson's Patients.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 9, p. 1500
- By:
- Publication type:
- Article
Test/Retest Reproducibility of Iodine-123-βCIT SPECT Brain Measurement of Dopamine Transporters in Parkinson's Patients.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 9, p. 1453
- By:
- Publication type:
- Article
Quantitation of Neuroreceptors: A Need to Increase Imaging Resolution?
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 11, p. 1911
- By:
- Publication type:
- Article
Comparison of Technetium-99m-HMPAO and Technetium-99m-ECD Cerebral SPECT Images in Alzheimer's Disease.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 11, p. 1749
- By:
- Publication type:
- Article
Reproducibility of Iodine-123-β-CIT SPECT Brain Measurement of Dopamine Transporters.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 2, p. 222
- By:
- Publication type:
- Article
Age-Related Decline in Striatal Dopamine Transporter Binding with Iodine-123-β-CITSPECT.
- Published in:
- Journal of Nuclear Medicine, 1995, v. 36, n. 7, p. 1175
- By:
- Publication type:
- Article
Aging gene signature of memory CD8<sup>+</sup> T cells is associated with neurocognitive functioning in Alzheimer's disease.
- Published in:
- Immunity & Ageing, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12979-023-00396-y
- By:
- Publication type:
- Article
Alzheimer disease neuropathology in a patient previously treated with aducanumab.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 1, p. 143, doi. 10.1007/s00401-022-02433-4
- By:
- Publication type:
- Article
Emotion Processing Dysfunction in Alzheimer's Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2022, v. 37, p. 1, doi. 10.1177/15333175221082834
- By:
- Publication type:
- Article
Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 3, p. 1, doi. 10.1002/trc2.12403
- By:
- Publication type:
- Article
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 2, p. 1, doi. 10.1002/trc2.12388
- By:
- Publication type:
- Article
Striatal dopamine transporter availability with [<sup>123</sup>I]β-CIT SPECT is unrelated to gender or menstrual cycle.
- Published in:
- Psychopharmacology, 2005, v. 183, n. 2, p. 181, doi. 10.1007/s00213-005-0158-5
- By:
- Publication type:
- Article
The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease.
- Published in:
- Psychopharmacology, 1997, v. 132, n. 3, p. 217, doi. 10.1007/s002130050339
- By:
- Publication type:
- Article
The calcium‐containing smooth endoplasmic reticulum is a focus of risk factors for early‐ and late‐onset Alzheimer's disease: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047651
- By:
- Publication type:
- Article
Validation of a simplified tissue‐to‐reference ratio measurement using SUVR for the assessment of synaptic density alterations in Alzheimer's disease using [<sup>11</sup>C]UCB‐J PET: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045928
- By:
- Publication type:
- Article
Recruitment for a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial: Prevention (nonpharmacological) / Exercise.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044658
- By:
- Publication type:
- Article
11C‐PBR28 brain PET imaging with lipopolysaccharide challenge for the study of microglia function in Alzheimer's disease: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043584
- By:
- Publication type:
- Article
Biochemical characterization of age‐related calcium‐cAMP‐PKA signaling dysregulation and its effect on tau pathology in rhesus monkey cortex: Molecular and cell biology/calcium homeostasis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042017
- By:
- Publication type:
- Article
ICA‐derived sources of synaptic density PET ([<sup>11</sup>C]UCB‐J) relate to cognitive impairment severity in Alzheimer's disease: Neuroimaging: Imaging the human synapse in AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041197
- By:
- Publication type:
- Article
In vivo measurement of widespread synaptic loss and associated tau accumulation in early Alzheimer's disease: Molecular imaging of novel biomarkers for neurodegeneration and ADRD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037791
- By:
- Publication type:
- Article
PBR28 Brain PET imaging with lipopolysaccharide challenge for the study of microglia function in Alzheimer's disease: Molecular imaging of novel biomarkers for neurodegeneration and ADRD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037792
- By:
- Publication type:
- Article
P4‐481: ASSOCIATION BETWEEN ENTORHINAL CORTICAL TAU ACCUMULATION AND HIPPOCAMPAL SYNAPTIC DENSITY IN OLDER INDIVIDUALS WITH NORMAL COGNITION AND EARLY ALZHEIMER'S DISEASE: PRELIMINARY EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1497, doi. 10.1016/j.jalz.2019.08.027
- By:
- Publication type:
- Article
P4‐143: LOSS OF PDE4D REGULATION OF CAMP‐PKA‐CALCIUM SIGNALING IN THE AGING ASSOCIATION CORTEX: INCREASING RISK FOR LOAD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1329, doi. 10.1016/j.jalz.2019.06.3804
- By:
- Publication type:
- Article
P2‐349: ASSOCIATION BETWEEN MGLUR5 AND SYNAPTIC DENSITY: A MULTI‐TRACER STUDY OF HEALTHY AGING AND ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P729, doi. 10.1016/j.jalz.2019.06.2756
- By:
- Publication type:
- Article
IC‐P‐140: ASSOCIATION BETWEEN MGLUR5 AND SYNAPTIC DENSITY: A MULTI‐TRACER STUDY IN HEALTHY AGING AND ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P115, doi. 10.1016/j.jalz.2019.06.4254
- By:
- Publication type:
- Article
IC‐P‐140: ASSOCIATION BETWEEN MGLUR5 AND SYNAPTIC DENSITY: A MULTI‐TRACER STUDY IN HEALTHY AGING AND ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P115, doi. 10.1016/j.jalz.2019.06.4254
- By:
- Publication type:
- Article
P4‐321: TAU PET IN A4: PRELIMINARY REPORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1583, doi. 10.1016/j.jalz.2018.07.144
- By:
- Publication type:
- Article
P4‐013: DESIGN OF A PHASE‐3 TRIAL (APECS) TO EVALUATE THE BACE INHIBITOR VERUBECESTAT IN PRODROMAL AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1436, doi. 10.1016/j.jalz.2018.06.2415
- By:
- Publication type:
- Article
P3‐088: THE AGING RHESUS MONKEY IS AN APPROPRIATE NEW ANIMAL MODEL FOR STUDYING THE ETIOLOGY AND TREATMENT OF TAU PATHOLOGY IN ASSOCIATION CORTEX.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1099, doi. 10.1016/j.jalz.2018.06.1444
- By:
- Publication type:
- Article
P2‐365: PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A) IN ALZHEIMER'S DISEASE: INITIAL EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P832, doi. 10.1016/j.jalz.2018.06.1056
- By:
- Publication type:
- Article
P1‐469: PET IMAGING OF METABOTROPIC GLUTAMATE RECEPTOR 5 BINDING IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P501, doi. 10.1016/j.jalz.2018.06.479
- By:
- Publication type:
- Article
P1‐274: A TARGETED MASS‐SPECTROMETRY METHOD FOR QUANTIFICATION OF CEREBROSPINAL FLUID BIOMARKERS OF ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P387, doi. 10.1016/j.jalz.2018.06.280
- By:
- Publication type:
- Article
IC‐P‐183: PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A) IN ALZHEIMER'S DISEASE: INITIAL EXPERIENCE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P152, doi. 10.1016/j.jalz.2018.06.2250
- By:
- Publication type:
- Article
IC‐04‐03: PET IMAGING OF METABOTROPIC GLUTAMATE RECEPTOR 5 BINDING IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P8, doi. 10.1016/j.jalz.2018.06.2051
- By:
- Publication type:
- Article